133 related articles for article (PubMed ID: 9249023)
21. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
22. cAMP-dependent stabilization of phosphoenolpyruvate carboxykinase mRNA in LLC-PK1-F+ kidney cells.
Dhakras PS; Hajarnis S; Taylor L; Curthoys NP
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F313-8. PubMed ID: 16144962
[TBL] [Abstract][Full Text] [Related]
23. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells.
Lee JS; von der Ahe D; Kiefer B; Nagamine Y
Nucleic Acids Res; 1993 Jul; 21(15):3365-72. PubMed ID: 8346015
[TBL] [Abstract][Full Text] [Related]
24. Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions.
Altus MS; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21190-6. PubMed ID: 1939161
[TBL] [Abstract][Full Text] [Related]
25. Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-Jun.
Lee JS; Favre B; Hemmings BA; Kiefer B; Nagamine Y
J Biol Chem; 1994 Jan; 269(4):2887-94. PubMed ID: 8300623
[TBL] [Abstract][Full Text] [Related]
26. AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and the cytoplasm.
Katz DA; Theodorakis NG; Cleveland DW; Lindsten T; Thompson CB
Nucleic Acids Res; 1994 Jan; 22(2):238-46. PubMed ID: 8121809
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone coordinately inhibits plasminogen activator gene expression and enzyme activity in porcine kidney cells.
Pearson D; Altus MS; Horiuchi A; Nagamine Y
Biochem Biophys Res Commun; 1987 Feb; 143(1):329-36. PubMed ID: 3827925
[TBL] [Abstract][Full Text] [Related]
28. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
29. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
31. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces binding of a 50 kDa protein on the 3' untranslated region of urokinase-type plasminogen activator mRNA.
Shimba S; Hayashi M; Sone H; Yonemoto J; Tezuka M
Biochem Biophys Res Commun; 2000 Jun; 272(2):441-8. PubMed ID: 10833433
[TBL] [Abstract][Full Text] [Related]
32. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex.
Kiledjian M; DeMaria CT; Brewer G; Novick K
Mol Cell Biol; 1997 Aug; 17(8):4870-6. PubMed ID: 9234743
[TBL] [Abstract][Full Text] [Related]
33. Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3'untranslated region of the murine inducible nitric-oxide synthase mRNA.
Söderberg M; Raffalli-Mathieu F; Lang MA
Mol Pharmacol; 2002 Aug; 62(2):423-31. PubMed ID: 12130696
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.
Shetty S
Mol Cell Biochem; 2002 Aug; 237(1-2):55-67. PubMed ID: 12236587
[TBL] [Abstract][Full Text] [Related]
35. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
36. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines.
Jans DA; Dierks-Ventling C; Hemmings BA
Exp Cell Res; 1987 Sep; 172(1):76-83. PubMed ID: 3653259
[TBL] [Abstract][Full Text] [Related]
37. Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.
Shetty S
Mol Cell Biochem; 2005 Apr; 272(1-2):107-18. PubMed ID: 16010978
[TBL] [Abstract][Full Text] [Related]
38. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
Shin S; Kim MK; Jung W; Chong Y
Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
[TBL] [Abstract][Full Text] [Related]
39. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L.
Shih SC; Claffey KP
J Biol Chem; 1999 Jan; 274(3):1359-65. PubMed ID: 9880507
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability.
Altus MS; Pearson D; Horiuchi A; Nagamine Y
Biochem J; 1987 Mar; 242(2):387-92. PubMed ID: 3593259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
